The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis

Chronic inflammation is one of the main determinants of atherogenesis. The traditional medications for treatment of atherosclerosis are not very efficient in targeting atherosclerotic inflammation. Most of these drugs are non-selective, anti-inflammatory and immunosuppressive agents that have advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdavi Gorabi, Armita, Kiaie, Nasim, Reiner, Željko, Carbone, Federico, Montecucco, Fabrizio, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769786/
https://www.ncbi.nlm.nih.gov/pubmed/31455044
http://dx.doi.org/10.3390/biom9090416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769786/
https://www.ncbi.nlm.nih.gov/pubmed/31455044
http://dx.doi.org/10.3390/biom9090416

Ejemplares similares